Testosterone levels are decreased in diabetic patients and recent studies have suggested that high-normal fasting glucose is a risk factor for cardiovascular disease. To further elucidate the relationship between plasma glucose and testosterone, we investigated the association between fasting plasma glucose (FPG) and endogenous sex hormones (serum total testosterone, sex hormone binding globulin, estradiol, and the ratio of testosterone to estradiol) in nondiabetic and pre-diabetic men.
INTRODUCTION
Testosterone is associated with bone mineral density, body composition, mood, aggression, cognitive function, and sexual function. 1) Several studies have reported decreased testosterone levels with metabolic syndrome, visceral obesity, atherosclerosis, and type 2 diabetes mellitus (DM) in men. [2] [3] [4] [5] [6] Studies have also suggested a relationship between fasting glucose and androgen levels in patients with diabetes, metabolic syndrome, coronary excess leptin may aff ect the suppression of sex hormone binding globulin (SHBG) activity and plasma testosterone. 10, 11) However, there is currently no data about these relationships in non-diabetic men with high-normal glucose levels or in pre-diabetic men.
Our previous study revealed that subjects with high-normal glucose levels were characterized by a high incidence of arterial stiff ness. 12) Th is suggests that fasting plasma glucose (FPG), even within the normal range, may aff ect androgen levels. Furthermore, this approach would be valuable because FPG can be easily measured in primary care sett ings and is a reversible risk factor.
In this study we assessed the relationship between FPG, total testosterone, and SHBG as well as the testosterone to estradiol ratio in non-diabetic men with high-normal glucose levels, and in pre-diabetic men. Multiple linear regression analysis was performed aft er adjusting for age, BMI, smoking, and alcohol consumption in order to identify any independent associations between testosterone and FPG. P-values less than 0.05 were considered statistically signifi cant. Figure 1 ). Aft er adjustment for age, BMI, smoking, and alcohol consumption, FPG was independently associated with total testosterone levels in the non-diabetic and pre-diabetic men (β = -0.082, P < 0.01) ( Table 3) . Total testosterone was signifi cantly decreased in non-diabetic subjects with high-normal glucose and IFG levels. In particular, subjects in the high FPG groups (above 88 mg/dL) showed decreased testosterone levels aft er adjusting for age, BMI, smoking, and alcohol consumption (Figure 2 ).
METHODS

Study Population
SHBG, estradiol, and the ratio of testosterone to estradiol were not correlated with FPG. 
DISCUSSION
In this study, FPG was negatively and independently associated with total testosterone in non-diabetic Korean men.
Interestingly, high-normal glucose and IFG levels were associated with a signifi cant decrease in serum total testosterone. FPG levels can be measured easily in the outpatient clinic sett ing, allowing for early intervention. Th erefore, we suggest that FPG levels could be an important marker for men's health risk assessment in nondiabetic patients.
In previous studies, testosterone was shown to be negatively correlated with insulin, leptin, and the homeostasis model assessment of insulin resistance. 13) Hyperinsulinemia may suppress SHBG synthesis and decrease serum testosterone, thereby regulating the levels of luteinizing hormone. Studies have also suggested that hyperinsulinemia may suppress testosterone synthesis in the testis. 10, 11, 14, 15) According to recent treatment guidelines, testosterone replacement therapy is recommended when total testosterone levels are below 8 nmol/L, while individuals with serum levels above 12 nmol/L are not categorized as having sexual dysfunction and are thus not candidates for replacement therapy. Although the cohort in this study had normal testosterone levels with no abnormal clinical signs indicating hypogonadism, glycemic levels should be carefully monitored considering the association between hypogonadal symptoms and diabetes. 6, 16) In our study, estradiol levels were not correlated with FPG. 8) Yasui et al. 17) and Dunajska et al. 18) reported a correlation between estradiol and FPG, although the subjects in their studies were Japanese and differences in demographics could account for the variation. Other lifestyle factors such as smoking were not associated with testosterone levels, and this fi nding was supported in a study by Halmenschlager et al. 19) Our study has some limitations with respect to extrapolating generalizations from our results. The narrow age range is useful since it suggests that men in this range should monitor their glycemic levels carefully. However, the results of this study cannot be applied to older individuals. Further research is needed to elucidate the relationship between testosterone and plasma glucose in older populations. Second, since insulin levels were not measured in our cohort, we cannot comment on the effect of insulin on testosterone metabolism. Finally, a recent study showed that up to 5% of subjects with IFG appear to have diabetes according to the 2-hour glucose tolerance test. 20) Th erefore, true-DM and IFG groups were not demarcated in the glucose tolerance test, implying that some individuals in the IFG group may actually have had DM.
Although this study has some limitations, we demonstrated that FPG is negatively and independently associated with total testosterone in non-diabetic, middle-aged Korean men, and may be a useful marker to control glycemic levels in order to prevent decreased testosterone levels in this population.
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